Header

UZH-Logo

Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 3.

Mocroft, A; Furrer, H J; Miro, J M; Reiss, P; Mussini, C; Kirk, O; Abgrall, S; Ayayi, S; Bartmeyer, B; Braun, D; Castagna, A; d'Arminio Monforte, A; Gazzard, B; Gutierrez, F; Hurtado, I; Jansen, K; Meyer, L; Muñoz, P; Obel, N; Soler-Palacin, P; Papadopoulos, A; Raffi, F; Ramos, J T; Rockstroh, J K; Salmon, D; Torti, C; Warszawski, J; de Wit, S; Zangerle, R; Fabre-Colin, C; Kjaer, J; Chene, G; Grarup, J; Lundgren, J D (2013). The incidence of AIDS-defining illnesses at a current CD4 count ≥ 200 cells/μL in the post-combination antiretroviral therapy era. Clinical Infectious Diseases, 57(7):1038-1047.

Murray, M; Hogg, R S; Lima, V D; May, M T; Moore, D M; Abgrall, S; Bruyand, M; D'Arminio Monforte, A; Tural, C; Gill, M J; Harris, R J; Reiss, P; Justice, A; Kirk, O; Saag, M; Smith, C J; Weber, R; Rockstroh, J; Khaykin, P; Sterne, J A C (2012). The effect of injecting drug use history on disease progression and death among HIV-positive individuals initiating combination antiretroviral therapy: collaborative cohort analysis. HIV Medicine, 13(2):89-97.

Mugavero, M J; May, M; Ribaudo, H J; Gulick, R M; Riddler, S A; Haubrich, R; Napravnik, S; Abgrall, S; Phillips, A; Harris, R; Gill, M J; de Wolf, F; Hogg, R; Günthard, H F; Chêne, G; D'Arminio Monforte, A; Guest, J L; Smith, C; Murillas, J; Berenguer, J; Wyen, C; Domingo, P; Kitahata, M M; Sterne, J A C; Saag, M S (2011). Comparative effectiveness of initial antiretroviral therapy regimens: ACTG 5095 and 5142 clinical trials relative to ART-CC cohort study. Journal of Acquired Immune Deficiency Syndromes, 58(3):253-260.

This list was generated on Wed Nov 22 00:12:45 2017 CET.